BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2020 12:21:39 PM | Browse: 460 | Download: 701
Publication Name World Journal of Clinical Cases
Manuscript ID 55130
Country/Territory China
Received
2020-03-14 02:59
Peer-Review Started
2020-03-14 03:05
To Make the First Decision
Return for Revision
2020-04-22 19:10
Revised
2020-04-26 00:44
Second Decision
2020-07-01 10:45
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-07-04 03:55
Articles in Press
2020-07-04 03:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-07-12 22:02
Typeset the Manuscript
2020-07-22 02:03
Publish the Manuscript Online
2020-07-24 12:21
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Case Report
Article Title Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
Manuscript Source Unsolicited Manuscript
All Author List Xing-Tong Wang, Wei Guo, Mo Sun, Wei Han, Zhong-Hua Du, Xiu-Xiu Wang, Bei-Bei Du and Ou Bai
ORCID
Author(s) ORCID Number
Xing-Tong Wang http://orcid.org/0000-0003-2253-1737
Wei Guo http://orcid.org/0000-0003-1982-7131
Mo Sun http://orcid.org/0000-0002-8154-7598
Wei Han http://orcid.org/0000-0003-3971-1400
Zhong-Hua Du http://orcid.org/0000-0001-6414-6680
Xiu-Xiu Wang http://orcid.org/0000-0002-9972-1080
Bei-Bei Du http://orcid.org/0000-0002-0991-5798
Ou Bai http://orcid.org/0000-0003-4066-9473
Funding Agency and Grant Number
Funding Agency Grant Number
Grant from Department of Finance of Jilin Province 2018SCZWSZX-031
Corresponding Author Ou Bai, MD, PhD, Chief Doctor, Professor, Department of Hematology, The First Hospital of Jilin University, Jilin Provincial Hematology Research Institute, National key Discipline, No. 71, Xinmin Street, Changchun 130021, Jilin Province, China. baiou@jlu.edu.cn
Key Words Hepatosplenic T-cell lymphoma; Gamma-delta T-cell lymphoma; Chidamide; Novel agent; Case report;
Core Tip Hepatosplenic T-cell lymphoma is a rare disease that progresses quickly and has poor prognosis. Patients usually show short-term rapid disease progress with a traditional inductive regimen, leaving no opportunity for hematopoietic stem cell transplantation. We employed the histone deacetylase inhibitors Chidamide combined with a dose-adjusted ifosfamide, carboplatin, etoposide regimen and Chidamide single-drug oral maintenance therapy for the management of this patient and turn out a satisfactory outcome.
Publish Date 2020-07-24 12:21
Citation Wang XT, Guo W, Sun M, Han W, Du ZH, Wang XX, Du BB, Bai O. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report. World J Clin Cases 2020; 8(14): 3122-3129
URL https://www.wjgnet.com/2307-8960/full/v8/i14/3122.htm
DOI https://dx.doi.org/10.12998/wjcc.v8.i14.3122
Full Article (PDF) WJCC-8-3122.pdf
Full Article (Word) WJCC-8-3122.docx
CARE Checklist–2016 55130-CARE-Checklist–2016-revision.pdf
Manuscript File 55130-Review-Filipodia.docx
Answering Reviewers 55130-Answering reviewers.pdf
Audio Core Tip 55130-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 55130-Conflict-of-interest statement.pdf
Copyright License Agreement 55130-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 55130-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 55130-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 55130-Language certificate.pdf
Peer-review Report 55130-Peer-review(s).pdf
Scientific Misconduct Check 55130-Scientific misconduct check.pdf
Scientific Editor Work List 55130-Scientific editor work list.pdf